Cancer survivors often report difficulties with memory and concentration—sometimes referred to by patients as “chemobrain” or “chemofog”. The results from two recent studies suggest that, while chemotherapy itself may not be associated with cognitive impairment, some patients might already be experiencing cognitive difficulties before treatment is even started.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Meyers, C. A. & Perry, J. R. (eds) Cancer and Cognition (Cambridge University Press, UK, 2008).
Jansen, C. E., Miaskowski, C., Dodd, M., Dowling, G. & Kramer, J. A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 104, 2222–2233 (2005).
Jenkins, V. et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br. J. Cancer 94, 828–834 (2006).
Schagen, S. B. et al. Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta Oncol. 47, 63–70 (2008).
Pedersen, A. D. et al. Long-term cognitive function following chemotherapy in patients with testicular cancer. J. Int. Neuropsychol. Soc. 15, 296–301 (2009).
Skaali, T. et al. A prospective study of neuropsychological functioning in testicular cancer patients. Ann. Oncol. doi:10.1093/annonc/mdq553.
Wefel, J. S. et al. Cognitive impairment in men with testicular cancer prior to adjuvant therapy. Cancer 117, 190–196 (2011).
Ahles, T. A. et al. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res. Treat. 110, 143–152 (2008).
Schagen, S. B., Das, E. & van Dam, F. S. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients. Psychooncology 18, 674–678 (2009).
Hermelink, K. et al. Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psychooncology 19, 1321–1328 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Zachariae, R., Mehlsen, M. Is chemotherapy associated with cognitive impairment?. Nat Rev Urol 8, 182–183 (2011). https://doi.org/10.1038/nrurol.2011.29
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2011.29
This article is cited by
-
Cognitive impairment in testicular cancer survivors 2 to 7 years after treatment
Supportive Care in Cancer (2015)
-
Une consultation mémoire en cancérologie: entre plainte et trouble...
Psycho-Oncologie (2013)